Jean X Y Sim
Overview
Explore the profile of Jean X Y Sim including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
10
Citations
191
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Kalimuddin S, Tham C, Chan Y, Hang S, Kunasegaran K, Chia A, et al.
Nat Microbiol
. 2025 Jan;
10(2):374-387.
PMID: 39794472
T cells have been identified as correlates of protection in viral infections. However, the level of vaccine-induced T cells needed and the extent to which they alone can control acute...
2.
Cai Y, Philip E, Arora S, Sim J, Chow W, Nazeha N, et al.
IJID Reg
. 2024 Sep;
12:100427.
PMID: 39281193
Objectives: We used a multi-state model, which mitigates time-dependent bias, to estimate the mortality, length of stay (LOS), and costs of methicillin-resistant (MRSA) infections in Singapore. Methods: We conducted a...
3.
Aung M, Venkatachalam I, Sim J, Wee L, Aung M, Yang Y, et al.
Antimicrob Steward Healthc Epidemiol
. 2024 May;
4(1):e88.
PMID: 38774116
Background: Real-time reverse-transcriptase polymerase chain reaction (RT-PCR) has been the gold standard for diagnosing coronavirus disease 2019 (COVID-19) but has a lag time for the results. An effective prediction algorithm...
4.
Ong E, Koh C, Tng D, Ooi J, Yee J, Chew V, et al.
Med
. 2023 Apr;
4(6):353-360.e2.
PMID: 37105176
Background: Post-mRNA vaccination-associated cardiac complication is a rare but life-threatening adverse event. Its risk has been well balanced by the benefit of vaccination-induced protection against severe COVID-19. As the rate...
5.
Low J, de Alwis R, Chen S, Kalimuddin S, Leong Y, Mah T, et al.
NPJ Vaccines
. 2022 Dec;
7(1):161.
PMID: 36513697
Coronavirus disease-19 (Covid-19) pandemic have demonstrated the importantance of vaccines in disease prevention. Self-amplifying mRNA vaccines could be another option for disease prevention if demonstrated to be safe and immunogenic....
6.
Ong E, Yee J, Ooi J, Syenina A, de Alwis R, Chen S, et al.
NPJ Vaccines
. 2022 Nov;
7(1):154.
PMID: 36443317
Remarkable potency has been demonstrated for mRNA vaccines in reducing the global burden of the ongoing COVID-19 pandemic. An alternative form of the mRNA vaccine is the self-amplifying mRNA (sa-mRNA)...
7.
Syenina A, Gan E, Toh J, de Alwis R, Lin L, Tham C, et al.
PLoS Biol
. 2022 May;
20(5):e3001643.
PMID: 35639676
Ensuring high vaccination and even booster vaccination coverage is critical in preventing severe Coronavirus Disease 2019 (COVID-19). Among the various COVID-19 vaccines currently in use, the mRNA vaccines have shown...
8.
Gu X, Sim J, Lee W, Cui L, Chan Y, Chang E, et al.
iScience
. 2022 Jan;
25(1):103644.
PMID: 35005566
Antibiotic-associated diarrhea (AAD) affects a significant proportion of patients receiving antibiotics. We sought to understand if differences in the gut microbiome would influence the development of AAD. We administered a...
9.
Tan J, Conceicao E, Wee L, Sim J, Venkatachalam I
J Am Geriatr Soc
. 2021 Apr;
69(7):1745-1747.
PMID: 33861868
No abstract available.
10.
Kalimuddin S, Tham C, Qui M, de Alwis R, Sim J, Lim J, et al.
Med
. 2021 Apr;
2(6):682-688.e4.
PMID: 33851143
Background: RNA vaccines against coronavirus disease 2019 (COVID-19) have demonstrated ∼95% efficacy in phase III clinical trials. Although complete vaccination consisted of 2 doses, the onset of protection for both...